Cerebral blood flow and metabolic abnormalities in Alzheimer's disease

被引:179
作者
Matsuda, H [1 ]
机构
[1] Natl Ctr Hosp Mental Nervous & Muscular Disorders, Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878551, Japan
关键词
Alzheimer's disease; SPECT; PET; regional cerebral blood flow; regional cerebral metabolic rate for glucose;
D O I
10.1007/BF02988596
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In this review I summarize observations of PET and SPECT studies about cerebral blood Row and metabolic abnormalities in Alzheimers disease. In very early AD flow or metabolism reduces first in the posterior cingulate gyrus and precuneus. This reduction may arise from functional deafferentation caused by primary neural degeneration in the remote area of the entorhinal cortex that is the first to be pathologically affected in AD. Then medial temporal structures and parietotemporal association cortex show Row or metabolic reduction as disease processes. The reason why Row or metabolism in medial temporal structures shows delay in starting to reduce in spite of the earliest pathological affection remains to be elucidated. It is likely that anterior cinpulate gyrus is functionally involved, since attention is the first non-memory domain to be affected, before deficits in language and visuospatial functions. However few reports have described involvement in the anterior cingulate: gyrus. Relationship between cerebral blood Row or metabolism and apolipoprotein E genotype has been investigated. Especially, the APOE epsilon4 allele: has been reported to increase risk and to lower onset age as a function of the inherited dose of the epsilon3 allele. Reduction of flow or metabolism in the posterior cingulate gyrus and precuneus has been reported even in presymptomatic nondemented subjects who were cognitively normal and had at least a single epsilon3 allele. On the contrary the relation of epsilon4 allele to the progression rate of AD has been controversial From neuroimaging approaches. PET and SPECT imaging has become to be quite useful fur assessing therapeutical effects of newly introduced treatment For AD. Recent investigations observed significant regional flow increase after donepezil hydrochloride treatment. Most of these observations have been made by applying computer assisted analysis of three-dimensional stereotactic surface projection or statistical parametric mapping instead of a conventional regions of interest technique.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [31] The effect of physical exercise on cerebral blood flow in Alzheimer's disease
    van der Kleij, Lisa A.
    Petersen, Esben T.
    Siebner, Hartwig R.
    Hendrikse, Jeroen
    Frederiksen, Kristian S.
    Sobol, Nanna A.
    Hasselbalch, Steen G.
    Garde, Ellen
    NEUROIMAGE-CLINICAL, 2018, 20 : 650 - 654
  • [32] The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease
    Hays, Chelsea C.
    Zlatar, Zvinka Z.
    Wierenga, Christina E.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (02) : 167 - 179
  • [33] A Longitudinal SPECT Study of Different Patterns of Regional Cerebral Blood Flow in Alzheimer's Disease with or without Diabetes
    Hirao, Kentaro
    Hanyu, Haruo
    Sato, Tomohiko
    Kanetaka, Hidekazu
    Shimizu, Soichiro
    Sakurai, Hirofumi
    Iwamoto, Toshihiko
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 62 - 74
  • [34] Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
    Zhang, Heng
    Wang, Yan
    Lyu, Diyang
    Li, Yan
    Li, Wenwen
    Wang, Qi
    Qin, Qi
    Wang, Xuechu
    Gong, Min
    Jiao, Haishan
    Liu, Wenying
    Jia, Jianping
    AGEING RESEARCH REVIEWS, 2021, 71
  • [35] Opiate receptor avidity and cerebral blood flow in Alzheimer's disease
    Cohen, RM
    Andreason, PJ
    Doudet, DJ
    Carson, RE
    Sunderland, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 148 (02) : 171 - 180
  • [36] Effect of rivastigmine on regional cerebral blood flow in Alzheimer’s disease
    Sevim Sureyya Cerci
    Yusuf Tamam
    Halil Kaya
    Mustafa Yildiz
    Seyfi Arslan
    Advances in Therapy, 2007, 24 : 611 - 621
  • [37] Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease
    Visser, Denise
    Wolters, Emma E.
    Verfaillie, Sander C. J.
    Coomans, Emma M.
    Timmers, Tessa
    Tuncel, Hayel
    Reimand, Juhan
    Boellaard, Ronald
    Windhorst, Albert D.
    Scheltens, Philip
    van Der Flier, Wiesje M.
    Ossenkoppele, Rik
    van Berckel, Bart N. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 3165 - 3175
  • [38] The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease
    vanDyck, CH
    Lin, CH
    Robinson, R
    Cellar, J
    Smith, EO
    Nelson, JC
    Arnsten, AFT
    Hoffer, PB
    PSYCHOPHARMACOLOGY, 1997, 132 (03) : 217 - 226
  • [39] Regional Cerebral Blood Flow Correlates of Neuropsychiatric Symptom Domains in Early Alzheimer's Disease
    Jeong, Hyeonseok
    Kang, Ilhyang
    Park, Jong-Sik
    Na, Seung-Hee
    Kim, Seunghee
    Yoon, Sujung
    Song, In-Uk
    Chung, Yong-An
    DIAGNOSTICS, 2022, 12 (05)
  • [40] Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease
    Hanyu, H
    Shimizu, T
    Tanaka, Y
    Takasaki, M
    Koizumi, K
    Abe, K
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 15 (04) : 177 - 182